Protea begins REDIChip shipments

Protea Biosciences Group Inc. has commenced shipments of REDIchips to clients in North America, Asia and Europe, the company announced Tuesday.

The chip was developed with financial support from the Defense Advanced Research Projects Agency (DARPA) in cooperation with a research team from George Washington University, General Electric Global Research and SRI International. The chips use resonance-enhanced desorption ionization (REDI) in order to reduce the time necessary to quantify and identify small molecules in biological fluid material.

"We are pleased to have commenced shipments of REDIchips to our customers. REDIchip greatly improves a researcher’s ability to rapidly detect and quantify small molecules in biofluids, in a contaminant-free environment," Protea CEO Steve Turner said. "REDIchip employs a highly organized, density nanopost array design that produces 27 million nanoposts for each 2-millimeter spot. REDIchip provides exceptional sensitivity and reproducibility of results.”

DARPA funded this project with $14 million to facilitate the development of technology that can identify mechanisms of a threat on an individual at the cellular level. These can include drugs, chemicals and other biological materials, and these disposable chips are meant to be used once and support a 96-spot target plate that can manage simple and complex biological mixtures.

Protea focuses on molecular information to provide solutions in life sciences, health and pharmaceutical industries.

Organizations in this Story

Protea USA

Want to get notified whenever we write about Protea USA ?
Next time we write about Protea USA, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.